Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | PLG | P00747 | 1/20 | 0.46 |
| ▸ | PLAT | P00750 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CCR2 | P41597 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1961978 | 1.00 | PKM (0.51) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL4159836 | 1.00 | PKM (0.51) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL1961977 | 1.00 | PKM (0.51) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL27748051 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL27480731 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL27480730 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL9746896 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL9578611 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL9578607 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL27748100 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023224114-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2023-11-23 | — | — | WO | disclosed |
| US-10619098-B2 | Ultraviolet light absorbers | TRANSITIONS OPTICAL, INC. (US) | 2020-04-14 | — | — | US | disclosed |
| EP-3201292-B1 | ULTRAVIOLET LIGHT ABSORBERS | TRANSITIONS OPTICAL INC (US) | 2018-08-01 | — | — | EP | disclosed |
| US-20170275534-A1 | ULTRAVIOLET LIGHT ABSORBERS | TRANSITIONS OPTICAL, INC. | 2017-09-28 | — | — | US | disclosed |
| EP-3201292-A1 | ULTRAVIOLET LIGHT ABSORBERS | Transitions Optical, Inc. (US) | 2017-08-09 | — | — | EP | disclosed |
| US-9441164-B2 | Isosorbide derivative, liquid crystal composition, liquid crystal element, and liquid crystal display device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-09-13 | — | — | US | disclosed |
| WO-2016053662-A1 | ULTRAVIOLET LIGHT ABSORBERS | TRANSITIONS OPTICAL, INC. (US) | 2016-04-07 | — | — | WO | disclosed |
| US-20150034868-A1 | ISOSORBIDE DERIVATIVE, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL ELEMENT, AND LIQUID CRYSTAL DISPLAY DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-02-05 | — | — | US | disclosed |
| US-8293146-B2 | Optical film and phase difference plate, and liquid crystal compound | FUJIFILM CORPORATION (JP) | 2012-10-23 | — | — | US | disclosed |
| US-20090159857-A1 | OPTICAL FILM AND PHASE DIFFERENCE PLATE, AND LIQUID CRYSTAL COMPOUND | FUJIFILM CORPORATION (JP) | 2009-06-25 | — | — | US | disclosed |
| WO-2007091716-A1 | OPTICAL FILM AND PHASE DIFFERENCE PLATE, AND LIQUID CRYSTAL COMPOUND | FUJIFILM CORPORATION (JP) | 2007-08-16 | — | — | WO | disclosed |
| EP-0393636-A2 | Liquid crystal composition and liquid crystal display using said composition | CHISSO CORPORATION (JP) | 1990-10-24 | — | — | EP | disclosed |
| WO-1990012073-A1 | TRIFLUOROMETHYLCYCLOHEXANE DERIVATIVES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1990-10-18 | — | — | WO | disclosed |
| EP-0332007-A1 | Derivatives of 2,3-difluorohydroquinone | MERCK PATENT GmbH (DE) | 1989-09-13 | — | — | EP | disclosed |
| US-4617140-A | Bicyclohexyl derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | disclosed |
| US-4323504-A | Cyclohexyl cyclohexyl dioxane liquid crystalline compounds and admixture containing same | TIMEX CORPORATION (US) | 1982-04-06 | — | — | US | disclosed |
| US-4323473-A | Cyclohexyl cyclohexyl dioxane liquid crystalline compounds and admixture containing same | TIMEX CORPORATION (US) | 1982-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090159857-A1 | OPTICAL FILM AND PHASE DIFFERENCE PLATE, AND LIQUID CRYSTAL COMPOUND | NOM1, CRYZ, CNN2 | PKM 4809/4885TP53 1634/4885HTT 4198/4885 |
| US-10619098-B2 | Ultraviolet light absorbers | ERCC1, MCM4, ERCC4 | PKM 3486/4885TP53 1138/4885HTT 337/4885 |
| US-20170275534-A1 | ULTRAVIOLET LIGHT ABSORBERS | MCM4, ERCC1, ERCC4 | PKM 4025/4885TP53 2008/4885HTT 256/4885 |
| US-20150034868-A1 | ISOSORBIDE DERIVATIVE, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL ELEMENT, AND LIQUID CRYSTAL DISPLAY DEVICE | AR, NR3C2, RCC2 | PKM 3255/4885TP53 2936/4885HTT 4133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.